Table 2.

Frequency (n) and percentage of comorbidities in AYA HOPE participants, by comorbidity index

Comorbidity index
AYA HOPECharlsonNCI
n (%)n (%)n (%)
Comorbidity categories
 Cardiovascular30 (6.2)12 (2.5)b
 Diabetes18 (3.7)18 (3.7)18 (3.7)
 Endocrine10 (2.1)b a
 Gastrointestinal20 (4.1)6 (1.2)5 (1.0)
 HIV/AIDS18 (3.7)18 (3.7)18 (3.7)
 Hypertension29 (6.0)29 (6.0)a
 Liver13 (2.7)13 (2.7)13 (2.7)
 Mental health40 (8.2)a a
 Neurologic42 (8.7)b b
 Obesity/overweight28 (5.8)a a
 Renal5 (1.0)b b
 Asthma/respiratory30 (6.1)30 (6.1)30 (6.1)
 Rhematologic/autoimmune5 (1.0)5 (1.0)5 (1.0)
 Hematologicb a a
Distribution of number of comorbidities
 0320 (66.4)381 (78.6)406 (83.7)
 194 (19.4)80 (16.5)66 (13.6)
 ≥271 (14.6)24 (4.9)13 (2.7)

NOTE: All indices are shown unweighted for accurate frequency comparisons.

  • aThe index does not include this comorbid condition.

  • bSuppressed because of fewer than 5 cases with this comorbid condition.